ArticleiScience2025

Identification of IL18/IL18R1 signaling as a predictive biomarker of SGLT2 inhibitor efficacy in type 2 diabetes.

I-Jou Teng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.